Banque Pictet & Cie SA Raises Stock Position in Intuitive Surgical, Inc. $ISRG

Banque Pictet & Cie SA lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.1% during the 2nd quarter, Holdings Channel reports. The firm owned 37,768 shares of the medical equipment provider’s stock after buying an additional 4,085 shares during the period. Banque Pictet & Cie SA’s holdings in Intuitive Surgical were worth $20,524,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Register Financial Advisors LLC lifted its holdings in Intuitive Surgical by 27.4% during the 2nd quarter. Register Financial Advisors LLC now owns 521 shares of the medical equipment provider’s stock worth $283,000 after buying an additional 112 shares in the last quarter. Fortune Financial Advisors LLC increased its position in shares of Intuitive Surgical by 18.4% during the second quarter. Fortune Financial Advisors LLC now owns 856 shares of the medical equipment provider’s stock worth $465,000 after acquiring an additional 133 shares during the period. Perigon Wealth Management LLC raised its stake in shares of Intuitive Surgical by 4.0% in the second quarter. Perigon Wealth Management LLC now owns 9,419 shares of the medical equipment provider’s stock valued at $5,118,000 after acquiring an additional 366 shares in the last quarter. Motive Wealth Advisors boosted its holdings in Intuitive Surgical by 8.1% in the second quarter. Motive Wealth Advisors now owns 440 shares of the medical equipment provider’s stock valued at $239,000 after purchasing an additional 33 shares during the period. Finally, McAdam LLC boosted its holdings in Intuitive Surgical by 10.1% in the second quarter. McAdam LLC now owns 738 shares of the medical equipment provider’s stock valued at $401,000 after purchasing an additional 68 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on ISRG shares. UBS Group upped their price target on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a report on Wednesday, July 23rd. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $595.95.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the transaction, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 in the last ninety days. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Down 1.3%

ISRG stock opened at $438.12 on Friday. The business has a 50 day moving average price of $470.98 and a 200 day moving average price of $501.82. The stock has a market cap of $157.06 billion, a price-to-earnings ratio of 61.10, a PEG ratio of 4.65 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the company earned $1.78 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.